A medical professional injects a treatment into a patient's knee.

According to OrthoInfo, knee osteoarthritis is a leading cause of disability in the United States. This degenerative joint disease brings pain and discomfort, impacting people’s lives significantly. Amidst various solutions, viscosupplementation, or hyaluronic acid knee injections, has gained popularity over the years.

Hyaluronic acid (HA) injections have been shown to ease knee osteoarthritis symptoms. While there’s no direct cure for this joint disease, these minimally invasive injections can give people a break from the pain, swelling, and stiffness. For individuals finding HA injection options, Durolane can deliver impressive pain-free optimal outcomes.

In this article, we will explore Durolane’s HA formulation and technology, the factors that set it apart, and the safety and versatility of this single-injection therapy.

Key Takeaways

  • Hyaluronic acid (HA) can help restore joint function and relieve the pain from OA symptoms.
  • Due to its components and process, the treatment effect can reach six months or longer, depending on the severity and activity of the target area.
  • Durolane relies on its highly purified and non-animal-derived hyaluronic acid (HA). The manufacturer biosynthesized it using bacterial fermentation to ensure it is free from animal proteins, reducing the risks of allergic reactions.
  • Fortunately, Durolane’s formulation and efficacy can act as a lubricant and shock absorber in the synovial fluid. 
  • It’s worth noting that only medical practitioners should administer these injections to maximize their benefits, results, and safety.

Understanding Hyaluronic Acid Therapies

In the aesthetic field, hyaluronic acid (HA) has rapidly become one of the top choices for minimally invasive procedures. Thanks to HA, it can add volume, contour the area, and rejuvenate the face. Fortunately, the potency of HA has reached the medical field, specifically in orthopedics. 

Hyaluronic acid (HA) is a naturally occurring substance in the body, mainly in the eyes, skin, and joints. HA can provide many benefits, including hydration, skin flexibility, and smooth movements. HA has effectively treated individuals’ skin and joint concerns worldwide thanks to various companies’ active research and development.

HA plays a crucial role in joint health. When HA decreases in the joints, it reduces synovial fluid. This causes discomfort and potentially leads to osteoarthritis (OA). HA can help restore joint function and relieve the pain from OA symptoms.

  • Lubrication and Cushioning: HA provides lubrication for the smooth movement of joint surfaces. It also promotes joint comfort by cushioning and reducing friction.
  • Moisture Retention: HA can retain water and moisture, which benefits the joints by maintaining moisture and lubrication. 
  • Joint Discomfort Support: HA can properly lubricate the joints for targeted pain relief when maintaining healthy and adequate synovial fluid.
  • Promote Mobility: HA can promote joint flexibility and mobility when the joints and cartilage are supported.

In this modern time, many current hyaluronic acid therapies for joint pain and osteoarthritis arise. Here are several treatment options for individuals suffering from OA.

  • Injections
  • Combination Therapy
  • Platelet-Rish Plasma (PRP)
  • Prolotherapy

Before undergoing treatment for OA, patients should consult their trusted medical professionals to know which treatment suits them. They can also create a tailored treatment plan to ensure your safety and the effectiveness of the therapy without compromising your overall health.

The Unique Formulation of Durolane

A hyaluronic acid substance.

What is Durolane used for? Medical professionals may recommend this injection treatment to individuals who have tried oral medications and other therapies that did not work. This single-injection therapy can treat the occurring symptoms of osteoarthritis.

So, how long does Durolane last? Due to its components and process, the treatment effect can reach six months or longer, depending on the severity and activity of the target area. Durolane stands out with its unique formulation and technology among hyaluronic acid injections for knee osteoarthritis.

  • Advanced Crosslinking Technology: Bioventus, the Durolane manufacturer, utilizes a unique injection process. They use non-animal stabilized hyaluronic acid or NASHA as the advanced crosslinking technology for their product. Durolane maintains molecular structure and resists quick degradation, offering longer-lasting relief results.
  • Optimal Viscosity and Durability: Durolane ensures its formulation achieves appropriate viscosity, which is crucial for its lubrication and shock absorber functions. This texture allows Durolane to effectively relieve pain and enhance patients’ mobility. 
  • Comparison with Conventional Hyaluronic Acid Injections: Durolane’s NASHA technology and optimal viscosity make It stand out among other options. Moreover, patients can expect six-month treatment relief after a single injection of Durolane. These factors significantly affect Durolane’s popularity among OA patients and medical practitioners.

Thanks to Bioventus’ efforts in creating a safe and effective temporary treatment for OA, Durolane allows patients to return to their active lifestyle after an injection session with their trusted medical professionals. It’s best to remember that these experts can offer less complication risks and optimal outcomes.

The Convenience Factor

One of Durolane’s advantages is its convenience factor, making it one of the top choices for treating OA symptoms. It’s worth noting that only medical practitioners should administer these injections to maximize their benefits, results, and safety. A single-injection therapy takes about 10 to 15 minutes, depending on the expert’s skills and treatment area.

So, when does Durolane work? This HA injection can bring relief in about two days after the treatment. Patients can entirely feel the symptomatic relief after two weeks. Its unique formulation ensures immediate and sustained relief for up to half a year. Patients can experience prolonged comfort and improved joint function.

Providing more extended periods of relief with Durolane’s single-injection therapy reduces the frequency of patients’ visits to their trusted physicians. With sustained and lasting results, it reduces the burden on patients and healthcare providers. This Durolane injection offers efficacy and convenience for both parties.

The Food and Drug Administration (FDA) approved Durolane injections for patients who have failed to respond to oral medications or other non-surgical treatments. This injection simplifies the treatment process for OA; instead of multiple treatments or medications, OA patients can receive a single Durolane injection for long-term symptom management. This makes Durolane a more efficient and less time-consuming procedure.

Safety Profile and Minimal Risk of Adverse Reactions

Patients must understand this safety profile, as well as the side effects and potential risks during or after the Durolane treatment. By learning this information, they can make informed healthcare decisions. Medical professionals can help individuals tremendously, as their expertise and skills allow them to explain and conduct the treatment clearly and smoothly.

Durolane relies on its highly purified and non-animal-derived hyaluronic acid (HA). It is also biosynthesized using bacterial fermentation to ensure it is free from animal proteins, reducing the risks of allergic reactions. When professionals inject Durolane, it acts as a lubricant and shock absorber for the joints. Durolane’s biocompatibility and tissue compatibility show it’s well-tolerated.

Despite Durolane being generally safe for most individuals, medical professionals and patients must remember a few contraindications. This can help them avoid the risks of adverse reactions during or after the injection procedure.

  • If patients have a knee joint infection, skin disease, or other infection around the injection site area.
  • If patients have known hypersensitivity or allergy to sodium hyaluronate preparations. 

The Durolane manufacturer or other studies have not tested the injection’s efficacy on breastfeeding or pregnant individuals and children. Medical professionals should also give information on the possible and common side effects that patients may encounter after the treatment.

It’s worth noting that these side effects typically do not last long and can range from mild to moderate. If any chance that reactions may persist longer or an allergic reaction occurs, promptly contact a qualified medical professional for urgent action.

  • Injection Site Pain
  • Joint Swelling
  • Joint Pain
  • Joint Stiffness
  • Redness’
  • Bruising
  • Puffiness
  • Warmth

Versatility in Orthopedic Practice

A licensed physician examining the knee of a patient.

The Durolane manufacturer continues its efforts in research and development to add more formulations and solutions for knee osteoarthritis and orthopedic practice. Its hyaluronic acid formulation and unique technology allow smooth movement of the affected joint and improve functionality.

Individuals should know that the FDA has only approved Durolane for treating pain in knee osteoarthritis. However, according to Durolane’s instructions, the injection treatment can address mild to moderate knee or hip osteoarthritis. Experts can safely apply Durolane to joints such as the shoulder, ankle, elbow, wrist, and toes.

Fortunately, Durolane’s formulation and efficacy can act as a lubricant and shock absorber in the synovial fluid. Its components can aid in restoring the balance of HA in the joint, leading to reduced pain and enhanced joint mobility. It may be a temporary treatment, but Durolane offers a comprehensive solution for individuals’ musculoskeletal needs.

A tailored treatment plan created by professionals and with patients’ engagement can build trust and a solid foundation between both parties. A thorough consultation and clear communication allow professionals to align the treatment plan based on the patient’s concerns and goals, as well as the product’s benefits. They can also explain the efficacy of shoulder, hip, and knee OA treatment.

Durolane has been used to treat mild to moderate symptoms of OA pain in the shoulder, hip, and knee areas. A Durolane single injection delivers symptomatic relief in patients with knee OA for up to six months. Individuals should seek a medical professional to administer these Durolane injections.

Conclusion

The hyaluronic acid injection, Durolane, offers significant advantages in orthopedic practice. It’s backed by its advanced crosslinking NASHA technology, convenience factors, safety, and versatility in treating knee osteoarthritis. The single-injection therapy can provide immediate and sustained symptomatic relief, offering individuals an improved quality of life.

Durolane’s versatility and effectiveness, matched with research and development, can provide more indications and a promising future for orthopedic treatments. It can shape future approaches to managing joint health and OA among individuals. Moreover, professionals’ tailored treatment plans for patients can provide safety, efficacy, and increased patient satisfaction after the treatment.

About: Medica Depot is your trusted all-in-one supplier, offering a range of high-quality medical injectables and supplies. We offer a worry-free experience in searching for the best and most popular products on the market, like Durolane. Whether for health professionals, plastic surgeons, dermatologists, licensed estheticians, or other specialists, we can offer genuine, brand-name products you may need. With Medica Depot, we prioritize serving you better to improve the patient’s quality of life.

References

  1. Viscosupplementation Treatment for Knee Arthritis – OrthoInfo – AAOS. (2015). Aaos.org. https://orthoinfo.aaos.org/en/treatment/viscosupplementation-treatment-for-knee-arthritis/
  2. DUROLANE® INSTRUCTIONS FOR USE. (2020). Bioventus OA Knee Pain Relief. https://durolane.com/wp-content/uploads/2021/04/00057764-Durolane-3-ml-IFU-90-47737-05_JAN_2020v4.pdf